Program Overview
Please read the following program information before accessing the presentations using links located at the bottom of this page.
Release Date: May 1, 2009 Expiration Date: March 1, 2011
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.5 hours (0.15 CEUs) of continuing education credit (program number 204-000-09-408-H05P).
Methods and Format
This is an online activity consisting of audio and slides for three presentations, a post-test, and an activity evaluation tool. Participants must view all presentations, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 1.5 hours. This activity is provided free of charge.
Target Audience
This activity is beneficial for pharmacists practicing or with an interest in the areas of cardiology and anticoagulation therapy. Pharmacists, including both clinicians and administrators, who are involved in ensuring compliance with Joint Commission standards or the development of anticoagulation guidelines and protocols would especially benefit from this program.
Activity Content
Click here to view an overview of the activity content.Learning Objectives
At the conclusion of this educational activity, participants should be able to
- List five of the most common compliance issues with the Joint Commission National Patient Safety Goal (NPSG) on Anticoagulation Management based on early 2009 experience and one method to correct each of these issues successfully.
- Describe the three requirements for a standardized protocol for anticoagulation therapy as required by the NPSG.
- Identify at least three challenges pharmacists face when managing anticoagulation therapy, as well as one potential solution for each of these challenges.
- Summarize key anticoagulation management issues not related to the NPSG.
Faculty
William E. Dager, Pharm.D., BCPS, FCSHP, FCCP, FCCM
Pharmacist Specialist, UC Davis Medical Center
Clinical Professor of Pharmacy
University of California, San Francisco
Clinical Professor of Medicine
University of California, Davis
Sacramento, California
Darryl S. Rich, Pharm. D., M.B.A., FASHP
Surveyor
The Joint Commission
Oakbrook Terrace, Illinois
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:William E. Dager, Pharm.D., BCPS, FCSHP, FCCP, FCCM, declares that he has no relationships pertinent to this activity.
Darryl S. Rich, Pharm. D., M.B.A., FASHP, declares that he has no relationships pertinent to this activity.
Catherine N. Klein, R.Ph., declares that she has no relationships pertinent to this activity.
Lorrie A. LeClair, Pharm.D., declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from sanofi-aventis U.S.
Launch Presentation
Early Experience with the Joint Commission National Patient Safety Goal (NPSG) on Anticoagulation Management: A Surveyor’s Perspective (30 minutes)
Optimizing Anticoagulation - Achieving Patient Safety and Outcomes (30 minutes)
Commentary on the “Clinical Pharmacist’s Perspective” (10 minutes)Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.
